{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:44:38Z","timestamp":1790084678043,"version":"4.0.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,2]]},"DOI":"10.1093\/cid\/ciy057","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T20:10:57Z","timestamp":1516651857000},"page":"221-228","source":"Crossref","is-referenced-by-count":50,"title":["Eggerthella lenta Bloodstream Infections Are Associated With Increased Mortality Following Empiric Piperacillin-Tazobactam (TZP) Monotherapy: A Population-based Cohort Study"],"prefix":"10.1093","volume":"67","author":[{"given":"Alejandra","family":"Ugarte-Torres","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Alberta Health Services, University of Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Gillrie","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Infectious Diseases, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P","family":"Griener","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Cumming School of Medicine, University of Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre L","family":"Church","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Department of Pathology & Laboratory Medicine and Medicine, University of Calgary, Section of Microbiology, Calgary Laboratory Services, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"key\n\t\t\t\t20180702005818_CIT0001","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JB.30.3.277-299.1935","article-title":"The gram-positive non-spore-bearing anaerobic bacilli of human feces","volume":"30","author":"Eggerth","year":"1935","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180702005818_CIT0002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1099\/00207713-49-4-1725","article-title":"Phylogenetic evidence for the transfer of Eubacterium lentum to the genus Eggerthella as Eggerthella lenta gen. nov., comb. nov","volume":"49 Pt 4","author":"Kageyama","year":"1999","journal-title":"Int J Syst Bacteriol"},{"key":"key\n\t\t\t\t20180702005818_CIT0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/00207713-49-2-595","article-title":"The family Coriobacteriaceae: reclassification of Eubacterium exiguum (Poco et al. 1996) and Peptostreptococcus heliotrinreducens (Lanigan 1976) as Slackia exigua gen. nov., comb. nov. and Slackia heliotrinireducens gen. nov., comb. nov., and Eubacterium lentum (Prevot 1938) as Eggerthella lenta gen. nov., comb. nov. Int","volume":"49","author":"Wade","year":"1999","journal-title":"J Syst Bacteriol"},{"key":"key\n\t\t\t\t20180702005818_CIT0004","first-page":"295","article-title":"Etudes de systematique bacterienne. 111. Invaliditi du genre Bacteroides Castellani et Chalmers. Demembrement et reclassification","volume":"60","author":"Prevot","year":"1938","journal-title":"Ann Inst Pasteur Paris"},{"key":"key\n\t\t\t\t20180702005818_CIT0005","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/ajcn\/27.12.1456","article-title":"Effect of diet on human fecal flora: comparison of Japanese and American diets","volume":"27","author":"Finegold","year":"1974","journal-title":"Am J Clin Nutr"},{"key":"key\n\t\t\t\t20180702005818_CIT0006","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1128\/AEM.66.1.375-382.2000","article-title":"Quantification of different Eubacterium spp. in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes","volume":"66","author":"Schwiertz","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0007","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/infdis\/160.6.1071","article-title":"Anaerobic bacterial bacteremia: 12-year experience in two military hospitals","volume":"160","author":"Brook","year":"1989","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0008","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1099\/jmm.0.45803-0","article-title":"Anaerobic, non-sporulating, gram-positive bacilli bacteraemia characterized by 16S rRNA gene sequencing","volume":"53","author":"Lau","year":"2004","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0009","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.anaerobe.2012.05.005","article-title":"Risk and prognostic factors among patients with bacteremia due to Eggerthella lenta","volume":"18","author":"Venugopal","year":"2012","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0010","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1128\/JCM.00548-12","article-title":"Clinical and microbiological characteristics of bacteremia caused by Eggerthella, Paraeggerthella, and Eubacterium species at a university hospital in Taiwan from 2001 to 2010","volume":"50","author":"Lee","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anaerobe.2017.04.010","article-title":"Eggerthella lenta bacteremia in solid tumor cancer patients: pathogen or witness of frailty","volume":"47","author":"Woerther","year":"2017","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0012","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1128\/JCM.02926-14","article-title":"Clinical and microbiological characteristics of Eggerthella lenta bacteremia","volume":"53","author":"Gardiner","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0013","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/512197","article-title":"Reemergence of anaerobic bacteremia","volume":"44","author":"Lassmann","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0014","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1128\/CMR.00002-14","article-title":"Population-based epidemiology and microbiology of community-onset bloodstream infections","volume":"27","author":"Laupland","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180702005818_CIT0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anaerobe.2015.11.005","article-title":"Microbiological diagnosis of Eggerthella lenta blood culture isolates in a Swedish tertiary hospital: rapid identification and antimicrobial susceptibility profile","volume":"38","author":"Liderot","year":"2016","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0016","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/jac\/dkl052","article-title":"Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999\u20132003","volume":"57","author":"Roberts","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180702005818_CIT0017","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0018","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t20180702005818_CIT0019","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/649554","article-title":"Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America","volume":"50","author":"Solomkin","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0020","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0021","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing, twenty-first informational supplement","author":"CLSI","year":"2011"},{"key":"key\n\t\t\t\t20180702005818_CIT0022","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.anaerobe.2008.01.001","article-title":"National hospital survey of anaerobic culture and susceptibility methods: III","volume":"14","author":"Goldstein","year":"2008","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0023","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0732-8893(95)00049-G","article-title":"Evaluation of the Etest for susceptibility testing of anaerobic bacteria","volume":"22","author":"Rosenblatt","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0024","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","author":"CLSI","year":"2018","edition":"28th"},{"key":"key\n\t\t\t\t20180702005818_CIT0025","volume-title":"Breakpoint tables for interpretation of MIC\u2019s and zone diameters","author":"The European Committee on Antimicrobial Susceptibility Testing","year":"2017"},{"key":"key\n\t\t\t\t20180702005818_CIT0026","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-012-0389-4","article-title":"Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections","volume":"41","author":"Ngo","year":"2013","journal-title":"Infection"},{"key":"key\n\t\t\t\t20180702005818_CIT0027","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1128\/JCM.36.3.752-755.1998","article-title":"Cellular fatty acid composition, soluble-protein profile, and antimicrobial resistance pattern of Eubacterium lentum","volume":"36","author":"Mosca","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0028","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1128\/AAC.01557-08","article-title":"Antianaerobic activity of sulopenem compared to six other agents","volume":"53","author":"Ednie","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005818_CIT0029","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1128\/AAC.48.3.1012-1016.2004","article-title":"In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections","volume":"48","author":"Edmiston","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005818_CIT0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/JCM.05395-11","article-title":"First comprehensive evaluation of the M.I.C. evaluator device compared to Etest and CLSI broth microdilution for MIC testing of aerobic gram-positive and gram-negative bacterial species","volume":"50","author":"Rennie","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180702005818_CIT0031","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20180702005818_CIT0032","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/AAC.46.1.220-224.2002","article-title":"In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds","volume":"46","author":"Hoellman","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005818_CIT0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.anaerobe.2016.07.003","article-title":"Changes in the antibiotic susceptibility of anaerobic bacteria from 2007\u20132009 to 2010\u20132012 based on the CLSI methodology","volume":"42","author":"Hastey","year":"2016","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.anaerobe.2014.05.004","article-title":"Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades","volume":"31","author":"Boyanova","year":"2015","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20180702005818_CIT0035","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/cid\/ciu395","article-title":"Antimicrobial resistance and susceptibility testing of anaerobic bacteria","volume":"59","author":"Schuetz","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180702005818_CIT0036","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/AAC.01136-13","article-title":"Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates","volume":"57","author":"Goldstein","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180702005818_CIT0037","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1128\/AAC.47.7.2334-2338.2003","article-title":"In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria","volume":"47","author":"Citron","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/67\/2\/221\/25103141\/ciy057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T23:39:17Z","timestamp":1603669157000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/67\/2\/221\/4823100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,1,24]]},"published-print":{"date-parts":[[2018,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy057","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,15]]},"published":{"date-parts":[[2018,1,24]]}}}